Display Options:

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Histamine H1 receptor antagonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Multiple Sclerosis; Sunburn; Angioedema; Conjunctivitis, Allergic; Hypersensitivity; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Rhinitis, Vasomotor; Urticaria

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Cytochrome P450 51 inhibitor
ROUTE OF ADMINISTRATION: ORAL; TOPICAL
STATUS: Approved
THERAPEUTIC AREA: IMMUNE SYSTEM; OTHER
THERAPEUTIC INDICATION: Alzheimer Disease; Asthma; Diabetes Mellitus, Type 2; Erectile Dysfunction; Essential Hypertension; Gastroparesis; Hepatitis C; Immune System Diseases; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Melanoma; Multiple Sclerosis; Nausea; Neuroblastoma; Osteoporosis; Premature Birth; Pulmonary Disease, Chronic Obstructive; Breast Neoplasms; Burns; Hypogonadism; Neoplasms; Prostatic Neoplasms; Psoriasis; Acne Vulgaris; Candidiasis, Vulvovaginal; Dermatitis; Prostatic Neoplasms, Castration-Resistant; Respiratory Distress Syndrome; Vaginosis, Bacterial; Adrenal Gland Diseases; Blastomycosis; Dermatitis, Seborrheic; Onychomycosis; Tinea; Tinea Pedis

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Breast Neoplasms

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Prostanoid EP1 receptor agonist
ROUTE OF ADMINISTRATION: INJECTION; URETHRAL
STATUS: Approved
THERAPEUTIC AREA: CARDIOVASCULAR; OTHER; UROLOGY AND KIDNEY
THERAPEUTIC INDICATION: Acute Kidney Injury; Arteriosclerosis Obliterans; Optic Neuropathy, Ischemic; Peripheral Arterial Disease; Peripheral Vascular Diseases; Respiratory Distress Syndrome; Severe Acute Respiratory Syndrome; Sexual Dysfunction, Physiological; Heart Failure; Macular Degeneration; Prostatic Neoplasms, Castration-Resistant; Cardiovascular Diseases; Ductus Arteriosus, Patent; Erectile Dysfunction

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Crohn Disease; Diabetes Mellitus, Type 2; Hodgkin Disease; Ischemic Stroke; Osteoarthritis, Knee; Respiratory Syncytial Virus Infections; Substance-Related Disorders; Arrhythmias, Cardiac; Epilepsies, Myoclonic; Pain; Severe Acute Respiratory Syndrome; Atrial Fibrillation; Bipolar Disorder; Diabetes Mellitus, Type 1; Heart Failure; Cardiovascular Diseases

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: GABA-A receptor; anion channel positive allosteric modulator
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Asthma; Diabetes Mellitus, Type 1; Migraine Disorders; Phobia, Social; Substance-Related Disorders; Epilepsy; Stress Disorders, Post-Traumatic; Dementia; Depressive Disorder; Schizophrenia; Seizures; Anxiety; Anxiety Disorders; Panic Disorder

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Soluble guanylate cyclase activator
ROUTE OF ADMINISTRATION: INJECTION; INTRA-ANAL; SUBLINGUAL; TRANSDERMAL
STATUS: Approved
THERAPEUTIC AREA: CARDIOVASCULAR; GASTROINTESTINAL; OTHER
THERAPEUTIC INDICATION: Hypertension, Pulmonary; Infections; Inflammation; Phlebitis; Rectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Diabetic Neuropathies; Erectile Dysfunction; Hot Flashes; Lung Neoplasms; Shock; Tendinopathy; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Muscle Cramp; Myocardial Ischemia; Osteoporosis; Raynaud Disease; Reperfusion Injury; Scleroderma, Localized; Stroke; Wounds and Injuries; Angina Pectoris; Cardiovascular Diseases; Coronary Artery Disease; Heart Failure; Hemorrhoids; Hypertension; Myocardial Infarction; Pain

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: GABA-A receptor; anion channel positive allosteric modulator
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Anxiety

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Peroxisome proliferator-activated receptor alpha agonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Anemia; Diabetes Mellitus, Type 2; HIV Infections; Hypertriglyceridemia; Neoplasms; Alcoholism; Myocardial Ischemia; Smoking Cessation; Tobacco Use Disorder; Abdominal Pain; Cardiovascular Diseases; Coronary Disease

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Tuberculosis; Pneumonia; Cystic Fibrosis; Mycobacterium Infections; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Bacterial Infections; Eye Infections

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Cystic Fibrosis; Coronary Disease; Demyelinating Diseases; Hyperparathyroidism, Primary; Migraine with Aura; Multiple Sclerosis, Chronic Progressive; Optic Neuritis; Hypertension; Cardiovascular Diseases

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Otitis Media; Communicable Diseases; Graft vs Host Disease; Abscess; Cholecystitis, Acute; Diabetic Foot; Enterobacteriaceae Infections; Hematologic Neoplasms; Infections; Influenza, Human; Pancreatic Neoplasms; Pneumonia; Pneumonia, Bacterial; Pseudomonas Infections; Pyelonephritis; Sepsis; Severe Acute Respiratory Syndrome; Shock, Septic; Urinary Tract Infections; Bacterial Infections

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: INHALATION; NASAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Rhinitis, Allergic, Perennial; Asthma; Lung Diseases, Obstructive; Nasal Obstruction; Rhinitis

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA inhibitor
ROUTE OF ADMINISTRATION: INJECTION; TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Leukemia; Myopia; Neoplasm Metastasis; Renal Insufficiency, Chronic; Urethral Stricture; Appendiceal Neoplasms; Biliary Tract Neoplasms; Carcinoma, Squamous Cell; Cholangiocarcinoma; Cholangitis, Sclerosing; Corneal Opacity; Esophageal Stenosis; Glaucoma, Neovascular; Glaucoma, Open-Angle; Keratoconus; Liver Neoplasms; Pterygium; Sarcoma; Anus Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma in Situ; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Colorectal Neoplasms; Head and Neck Neoplasms; Lung Neoplasms; Mesothelioma; Nasopharyngeal Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Adenocarcinoma; Glaucoma; Neoplasms

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Hypersensitivity

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: GABA-A receptor; anion channel positive allosteric modulator
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Anxiety; Dementia; Depressive Disorder; Pulmonary Disease, Chronic Obstructive; Schizophrenia; Sleep Initiation and Maintenance Disorders

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Beta-2 adrenergic receptor agonist
ROUTE OF ADMINISTRATION: INHALATION
STATUS: Approved
THERAPEUTIC AREA: OTHER; RESPIRATORY
THERAPEUTIC INDICATION: Depressive Disorder, Major; Diabetes Mellitus; Glycogen Storage Disease Type II; Idiopathic Pulmonary Fibrosis; Lymphangioleiomyomatosis; Myasthenic Syndromes, Congenital; Tachypnea; Bronchiolitis; Cough; Familial Primary Pulmonary Hypertension; Hypersensitivity; Memory Disorders; Pulmonary Edema; Respiratory Insufficiency; Spinal Cord Injuries; Status Asthmaticus; Dysautonomia, Familial; Heart Failure; Hypertension, Pulmonary; Lung Diseases; Organophosphate Poisoning; Rhinitis, Allergic, Seasonal; Asthma, Exercise-Induced; Bronchial Spasm; Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Voltage-gated L-type calcium channel blocker
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Adrenal Hyperplasia, Congenital; Substance-Related Disorders; Anus Diseases; Epilepsies, Partial; Fissure in Ano; Proteinuria; Renal Insufficiency, Chronic; Diabetic Nephropathies; Hypertension, Pulmonary; Kidney Calculi; Myocardial Ischemia; Placenta Previa; Pre-Eclampsia; Premature Birth; Raynaud Disease; Cardiovascular Diseases; Coronary Vasospasm; Hypertension

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Depression, Postpartum; Sleep Apnea, Obstructive; Alcoholism; Diabetic Neuropathies; Alzheimer Disease; Anxiety; Dementia; Depressive Disorder, Major; Schizophrenia; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Depressive Disorder

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Adenosine receptor antagonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Lung Diseases, Obstructive

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Appendicitis; Peritonitis; Sepsis; Bacterial Infections

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Dihydropteroate synthetase inhibitor
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Anemia; HIV Infections; Malaria; Malaria, Falciparum; Malaria, Vivax; Pneumonia, Pneumocystis; Pregnancy; Premature Birth

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Histamine H1 receptor antagonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Hypersensitivity

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: GABA-A receptor; anion channel positive allosteric modulator
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Epilepsy

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Obesity; Brain Injuries; Brain Ischemia; Delirium; Hypothermia; Obsessive-Compulsive Disorder; Panic Disorder; Coronary Disease; Ischemic Stroke

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Melanoma

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Sodium/potassium-transporting ATPase inhibitor
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Cystic Fibrosis; Cardiovascular Diseases

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Anxiety

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Cyclooxygenase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Amyloid Neuropathies, Familial; Diabetes Mellitus, Type 2; Arthritis, Rheumatoid; Fever; Osteoarthritis; Pain

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Acetylcholinesterase inhibitor
ROUTE OF ADMINISTRATION: TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Lice Infestations; Ectoparasitic Infestations

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Diagnostic agent
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Parkinson Disease

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Cell membrane inhibitor
ROUTE OF ADMINISTRATION: VAGINAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Progesterone receptor agonist
ROUTE OF ADMINISTRATION: IMPLANTATION; INTRAUTERINE; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER; PREGNANCY AND GYNECOLOGY
THERAPEUTIC INDICATION: Diabetes Mellitus, Type 2; Hepatitis B, Chronic; Hepatitis C, Chronic; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms; Non-alcoholic Fatty Liver Disease; Adenomyosis; HIV Infections; Ovarian Neoplasms; Pain; Anorexia Nervosa; Bone Diseases, Metabolic; Dysmenorrhea; Endometrial Hyperplasia; Endometriosis; Hemorrhage; Migraine Disorders; Menorrhagia

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: D2-like dopamine receptor antagonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Anxiety; Dementia; Depressive Disorder; Schizophrenia; Psychotic Disorders